{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T16:48:21Z","timestamp":1767372501307},"reference-count":45,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2009,11,1]],"date-time":"2009-11-01T00:00:00Z","timestamp":1257033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Behavioural Brain Research"],"published-print":{"date-parts":[[2009,11]]},"DOI":"10.1016\/j.bbr.2009.05.012","type":"journal-article","created":{"date-parts":[[2009,5,19]],"date-time":"2009-05-19T09:23:08Z","timestamp":1242724988000},"page":"232-239","source":"Crossref","is-referenced-by-count":13,"title":["Ampullosporin A, a peptaibol from Sepedonium ampullosporum HKI-0053 with neuroleptic-like activity"],"prefix":"10.1016","volume":"203","author":[{"given":"I.","family":"Berek","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Becker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Schr\u00f6der","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"H\u00e4rtl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V.","family":"H\u00f6llt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Grecksch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.bbr.2009.05.012_bib1","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1111\/j.1600-0773.1982.tb01032.x","article-title":"Pharmacological specificity of conditioned avoidance response inhibition in rats: inhibition by neuroleptics and correlation to dopamine receptor blockade","volume":"51","author":"Arnt","year":"1982","journal-title":"Acta Pharmacol Toxicol (Copenh)"},{"key":"10.1016\/j.bbr.2009.05.012_bib2","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/j.pnpbp.2004.06.019","article-title":"Ketamine-induced changes in rat behaviour: a possible animal model of schizophrenia. Test of predictable validity","volume":"28","author":"Becker","year":"2004","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.bbr.2009.05.012_bib3","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/S0278-5846(03)00080-0","article-title":"Ketamine-induced changes in rat behaviour: a possible animal model of schizophrenia","volume":"27","author":"Becker","year":"2003","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.bbr.2009.05.012_bib4","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s002130051015","article-title":"Social behavior in rats lesioned with ibotenic acid in the rat hippocampus: quantitative and qualitative analysis","volume":"144","author":"Becker","year":"1999","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bbr.2009.05.012_bib5","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1517\/13543776.13.4.425","article-title":"Novel antipsychotic agents: recent advances in the drug treatment of schizophrenia","volume":"13","author":"Butini","year":"2003","journal-title":"Expert Opin Ther Pat"},{"key":"10.1016\/j.bbr.2009.05.012_bib6","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S0024-3205(97)00228-2","article-title":"Neurotransmitter aberrations in schizophrenia: new perspectives and therapeutic implications","volume":"61","author":"Carlsson","year":"1997","journal-title":"Life Sci"},{"issue":"Suppl.","key":"10.1016\/j.bbr.2009.05.012_bib7","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1192\/S0007125000293574","article-title":"A glutamatergic deficiency model of schizophrenia","volume":"37","author":"Carlsson","year":"1999","journal-title":"Br J Psychiatry"},{"key":"10.1016\/j.bbr.2009.05.012_bib8","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1146\/annurev.pharmtox.41.1.237","article-title":"Interactions between monoamines, glutamate, and GABA in schizophrenia: new evidence","volume":"41","author":"Carlsson","year":"2001","journal-title":"Ann Rev Pharmacol Toxicol"},{"key":"10.1016\/j.bbr.2009.05.012_bib9","doi-asserted-by":"crossref","first-page":"267","DOI":"10.2174\/0929867043456034","article-title":"Schizophrenia: from dopamine to glutamate and back","volume":"11","author":"Carlsson","year":"2004","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.bbr.2009.05.012_bib10","first-page":"818","article-title":"Effects of drugs on avoidance and escape behavior","volume":"23","author":"Cook","year":"1964","journal-title":"Fed Proc"},{"key":"10.1016\/j.bbr.2009.05.012_bib11","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/0091-3057(95)00072-5","article-title":"Clozapine but not haloperidol antagonizes an MK-801 discriminative stimulus cue","volume":"51","author":"Corbett","year":"1995","journal-title":"Pharmacol Biochem Behav"},{"key":"10.1016\/j.bbr.2009.05.012_bib12","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/BF02246146","article-title":"Antipsychotic agents antagonize non-competitive N-methyl-d-aspartate antagonist-induced behaviors","volume":"120","author":"Corbett","year":"1995","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.bbr.2009.05.012_bib13","doi-asserted-by":"crossref","first-page":"977","DOI":"10.7164\/antibiotics.48.977","article-title":"Chrysospermins, new peptaibol antibiotics from Apiocrea chrysosperma Ap101","volume":"48","author":"Dornberger","year":"1995","journal-title":"J Antibiot (Tokyo)"},{"key":"10.1016\/j.bbr.2009.05.012_bib14","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1002\/(SICI)1521-3773(20000515)39:10<1860::AID-ANIE1860>3.0.CO;2-F","article-title":"Channel-forming peptaibols are potent elicitors of plant secondary metabolism and tendril coiling","volume":"39","author":"Engelberth","year":"2000","journal-title":"Angew Chem Int Ed Engl"},{"key":"10.1016\/j.bbr.2009.05.012_bib15","article-title":"The social interaction test of anxiety","author":"File","year":"1993","journal-title":"Neurosci Protoc"},{"key":"10.1016\/j.bbr.2009.05.012_bib16","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/BF00422565","article-title":"Effects of orotic acid on the development of morphine tolerance","volume":"36","author":"Grecksch","year":"1974","journal-title":"Psychopharmacology"},{"key":"10.1016\/j.bbr.2009.05.012_bib17","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S1567-5394(02)00056-7","article-title":"Differences in ion-channel formation by ampullosporins B, C, D and semisynthetic desacetyltryptophanyl ampullosporin A","volume":"57","author":"Grigoriev","year":"2002","journal-title":"Bioelectrochemistry"},{"key":"10.1016\/j.bbr.2009.05.012_bib18","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1002\/psc.502","article-title":"Differences in membrane pore formation by peptaibols","volume":"9","author":"Grigoriev","year":"2003","journal-title":"J Pept Sci"},{"key":"10.1016\/j.bbr.2009.05.012_bib19","first-page":"279","article-title":"Correlation in rats between the locomotor and avoidance suppressant potencies of eight phenothiazine tranquilizers","volume":"132","author":"Irwin","year":"1961","journal-title":"Arch Int Pharmacodyn Ther"},{"key":"10.1016\/j.bbr.2009.05.012_bib20","first-page":"104","article-title":"Is it possible to predict the clinical effects of neuroleptic drugs (major tranquillizers) from animal data? I. \u201cNeuroleptic activity spectra\u201d for rats","volume":"15","author":"Janssen","year":"1965","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/j.bbr.2009.05.012_bib21","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0924-977X(97)00041-2","article-title":"Drug treatment of the negative symptoms of schizophrenia","volume":"8","author":"King","year":"1998","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/j.bbr.2009.05.012_bib22","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1515\/nf-2002-0305","article-title":"Tiermodelle in der Schizophrenie-Forschung","volume":"3","author":"Koch","year":"2002","journal-title":"Neuroforum"},{"key":"10.1016\/j.bbr.2009.05.012_bib23","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/0304-3940(94)90248-8","article-title":"A new animal model of dopamine supersensitivity using s.c. implantation of haloperidol releasing polymers","volume":"170","author":"K\u00f6hler","year":"1994","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.bbr.2009.05.012_bib24","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1002\/psc.495","article-title":"Crystal structure and conformational analysis of ampullosporin","volume":"9","author":"Kronen","year":"2003","journal-title":"J Pept Sci"},{"key":"10.1016\/j.bbr.2009.05.012_bib25","doi-asserted-by":"crossref","first-page":"175","DOI":"10.7164\/antibiotics.54.175","article-title":"Ampullosporines B, C, D, E1, E2, E3 and E4 from Sepedonium ampullosporum HKI-0053: structures and biological activities","volume":"54","author":"Kronen","year":"2001","journal-title":"J Antibiot (Tokyo)"},{"issue":"Suppl. A","key":"10.1016\/j.bbr.2009.05.012_bib26","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.clinthera.2005.07.017","article-title":"Mechanism of action of antipsychotic drugs: from dopamine D(2) receptor antagonisms to glutamate NMDA facilitation","volume":"27","author":"Laruelle","year":"2005","journal-title":"Clin Ther"},{"key":"10.1016\/j.bbr.2009.05.012_bib27","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/sj.mp.4001556","article-title":"Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs","volume":"10","author":"Miyamoto","year":"2005","journal-title":"Mol Psychiatry"},{"key":"10.1016\/j.bbr.2009.05.012_bib28","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1002\/psc.459","article-title":"Circular dichroism studies of ampullosporin-A analogues","volume":"9","author":"Nguyen","year":"2003","journal-title":"J Pept Sci"},{"key":"10.1016\/j.bbr.2009.05.012_bib29","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.1021\/jm0208018","article-title":"Synthesis and biological evaluation of analogues of the peptaibol ampullosporin A","volume":"45","author":"Nguyen","year":"2002","journal-title":"J Med Chem"},{"key":"10.1016\/j.bbr.2009.05.012_bib30","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.pnpbp.2005.11.010","article-title":"Differential effects of classical neuroleptics and a newer generation antipsychotics on the MK-801 induced behavioural primitivization in mouse","volume":"30","author":"Nilsson","year":"2006","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"10.1016\/j.bbr.2009.05.012_bib31","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1001\/archpsyc.1995.03950240016004","article-title":"Glutamate receptors dysfunction and schizophrenia","volume":"52","author":"Olney","year":"1995","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/j.bbr.2009.05.012_bib32","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1002\/psc.529","article-title":"A nonribosomal peptide synthetase involved in the biosynthesis of ampullosporins in Sepedonium ampullosporum","volume":"9","author":"Reiber","year":"2003","journal-title":"J Pept Sci"},{"key":"10.1016\/j.bbr.2009.05.012_bib33","doi-asserted-by":"crossref","first-page":"722","DOI":"10.7164\/antibiotics.50.722","article-title":"Ampullosporin, a new peptaibol-type antibiotic from Sepedonium ampullosporum HKI-0053 with neuroleptic activity in mice","volume":"50","author":"Ritzau","year":"1997","journal-title":"J Antibiot (Tokyo)"},{"key":"10.1016\/j.bbr.2009.05.012_bib34","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/00008877-199601000-00001","article-title":"Phencyclidine-induced stereotyped behaviour and social isolation in rats: a possible animal model of schizophrenia","volume":"7","author":"Sams-Dodd","year":"1996","journal-title":"Behav Pharmacol"},{"key":"10.1016\/j.bbr.2009.05.012_bib35","first-page":"196","article-title":"Effect of novel antipsychotic drugs on phencyclidine-induced stereotyped behaviour and social isolation in the rat social interaction test","volume":"8","author":"Sams-Dodd","year":"1997","journal-title":"Behav Pharmacol"},{"key":"10.1016\/j.bbr.2009.05.012_bib36","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1517\/14728222.8.6.631","article-title":"The search for novel antipsychotics: pharmacological and molecular targets","volume":"8","author":"Sanger","year":"2004","journal-title":"Expert Opin Ther Targets"},{"key":"10.1016\/j.bbr.2009.05.012_bib37","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1111\/j.1471-4159.1993.tb03248.x","article-title":"Glutamate binding to brain membranes is increased in pentylenetetrazole-kindled rats","volume":"60","author":"Schr\u00f6der","year":"1993","journal-title":"J Neurochem"},{"key":"10.1016\/j.bbr.2009.05.012_bib38","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1016\/S0140-6736(98)07549-7","article-title":"Schizophrenia","volume":"353","author":"Schultz","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/j.bbr.2009.05.012_bib39","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1177\/070674370204700106","article-title":"Atypical antipsychotics: mechanism of action","volume":"47","author":"Seeman","year":"2002","journal-title":"Can J Psychiatry"},{"key":"10.1016\/j.bbr.2009.05.012_bib40","doi-asserted-by":"crossref","first-page":"343","DOI":"10.2174\/0929867043456043","article-title":"New antipsychotics and schizophrenia: a review on efficacy and side effects","volume":"11","author":"Serretti","year":"2004","journal-title":"Curr Med Chem"},{"key":"10.1016\/j.bbr.2009.05.012_bib41","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1017\/S1092852900001097","article-title":"Pharmacologic treatment of schizophrenia: what the future holds","volume":"6","author":"Tandon","year":"2001","journal-title":"CNS Spectr"},{"key":"10.1016\/j.bbr.2009.05.012_bib42","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.schres.2004.05.005","article-title":"Glutamatergic drugs for schizophrenia: a systematic review and meta-analysis","volume":"72","author":"Tuominen","year":"2005","journal-title":"Schizophr Res"},{"key":"10.1016\/j.bbr.2009.05.012_bib43","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S0149-7634(99)00037-8","article-title":"The conditioned avoidance response test re-evaluated: is it a sensitive test for the detection of potentially atypical antipsychotics?","volume":"23","author":"Wadenberg","year":"1999","journal-title":"Neurosci Biobehav Rev"},{"issue":"Suppl. 4","key":"10.1016\/j.bbr.2009.05.012_bib44","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/00004850-199709004-00006","article-title":"Cognitive function in schizophrenia","volume":"12","author":"Weinberger","year":"1997","journal-title":"Int Clin Psychopharmacol"},{"key":"10.1016\/j.bbr.2009.05.012_bib45","first-page":"1","article-title":"Zur Pharmakologie acylierter Phenothiazin-Derivate","volume":"115","author":"Wirth","year":"1958","journal-title":"Arch Int Pharmacodyn Ther"}],"container-title":["Behavioural Brain Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432809003118?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166432809003118?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,10,5]],"date-time":"2021-10-05T20:55:24Z","timestamp":1633467324000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166432809003118"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,11]]},"references-count":45,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2009,11]]}},"alternative-id":["S0166432809003118"],"URL":"https:\/\/doi.org\/10.1016\/j.bbr.2009.05.012","relation":{},"ISSN":["0166-4328"],"issn-type":[{"value":"0166-4328","type":"print"}],"subject":[],"published":{"date-parts":[[2009,11]]}}}